Trevarx Biomedical Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$35M
- Investors
-
4
Trevarx Biomedical General Information
Description
Developer of novel small-molecule radiopharmaceutical platforms designed to provide an oncology paradigm that identifies and cures cancer. The company offers small-molecule PARP inhibitor analogues paired with diagnostic biomarkers and cytotoxic radioactive payloads, enabling oncology researchers and clinicians to detect tumor expression levels and deliver precision treatment in cancers such as neuroblastoma and ovarian cancer.
Contact Information
Website
www.trevarx.comCorporate Office
- 2929 Arch Street
- Floor 3
- Philadelphia, PA 19104
- United States
Corporate Office
- 2929 Arch Street
- Floor 3
- Philadelphia, PA 19104
- United States
Trevarx Biomedical Timeline
Trevarx Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series A) | 24-Oct-2025 | $35M | In Progress | Clinical Trials - Phase 2 | ||
| 9. Mezzanine | 04-Aug-2025 | Completed | Clinical Trials - Phase 2 | |||
| 8. Accelerator/Incubator | 01-Jan-2025 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 01-Sep-2023 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | Completed | Clinical Trials - Phase 2 | ||||
| 5. Later Stage VC | 20-Sep-2022 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 31-Mar-2022 | Completed | Startup | |||
| 3. Grant | 01-Mar-2021 | Completed | Startup | |||
| 2. Seed Round | 02-Aug-2019 | $650K | $650K | Completed | Startup | |
| 1. University Spin-Out | 15-Aug-2016 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Trevarx Biomedical Signals
Trevarx Biomedical Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HiveBio | Accelerator/Incubator | |||
| NASA SBIR/STTR | Government | |||
| National Institutes of Health | Government | |||
| University of Pennsylvania | University |
Trevarx Biomedical FAQs
-
When was Trevarx Biomedical founded?
Trevarx Biomedical was founded in 2016.
-
Where is Trevarx Biomedical headquartered?
Trevarx Biomedical is headquartered in Philadelphia, PA.
-
What is the size of Trevarx Biomedical?
Trevarx Biomedical has 3 total employees.
-
What industry is Trevarx Biomedical in?
Trevarx Biomedical’s primary industry is Drug Delivery.
-
Is Trevarx Biomedical a private or public company?
Trevarx Biomedical is a Private company.
-
What is Trevarx Biomedical’s current revenue?
The current revenue for Trevarx Biomedical is .
-
How much funding has Trevarx Biomedical raised over time?
Trevarx Biomedical has raised $1.5M.
-
Who are Trevarx Biomedical’s investors?
HiveBio, NASA SBIR/STTR, National Institutes of Health, and University of Pennsylvania have invested in Trevarx Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process